key: cord-0908910-3jw3mi4b
authors: Wu, Yu-Hsueh; Wu, Yang-Che; Lang, Ming-Jane; Lee, Yi-Pang; Jin, Ying-Tai; Chiang, Chun-Pin
title: Review of oral ulcerative lesions in COVID-19 patients: A comprehensive study of 51 cases
date: 2021-07-15
journal: J Dent Sci
DOI: 10.1016/j.jds.2021.07.001
sha: 0da47a948abafb57d1d59d15025c3b0d00c86d39
doc_id: 908910
cord_uid: 3jw3mi4b

Numerous oral manifestations of COVID-19 have been reported in the literatures. Common oral lesions in COVID-19 patients included ulcerations, xerostomia, dysgeusia, gingival inflammation, and erythema. Among them, oral ulceration is the most frequent finding and is present as various but distinct patterns. Thus, we conducted a comprehensive review of 51 COVID-19 patients with oral ulcerative lesions to further analyze the various oral ulcerative lesions in COVID-19 patients. There were a median age of 41.4 years and a slight female predilection in these patients. Most oral lesions manifested as an aphtha-like ulceration but lack of an evidence of recurrent aphthous stomatitis. Some of them were present as herpetiform ulcerations without HSV infection. Widespread ulcerations accompanied with necrosis were observed in the more severe and immunosuppressed older patients. Although some reported patients were asymptomatic, most of them had systemic symptoms concurring or slightly preceding the oral ulcerative lesions and the latency from the onset of systemic symptoms to oral ulcerative lesions were under 10 days, suggesting that oral ulceration was one of the early symptoms of COVID-19. Therefore, the oral ulcerative lesions may be considered as oral markers for early diagnosis of the underlying COVID-19 infection in the asymptomatic patients.

In the end of 2019, an acute respiratory illness appeared abruptly and soon spread worldwide, which was officially named coronavirus disease-19 , and the virus responsible for this disease was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by World Health Organization (WHO). The common clinical presentations of COVID-19 included fever, cough, sore throat, runny nose, myalgia, fatigue, and dyspnea. Less frequently, sputum production, headache, and diarrhea were also observed. 1 Wang et al. 2 reported the hematological and radiographic alterations in the patients infected by SARS-CoV-2 in their study.

Lymphopenia is found in 70.3% patients, and prolonged prothrombin time occurs in 58% patients. Chest computed tomography shows patchy opacities or "ground-glass" pattern in lungs. The median age of the diagnosed patients is 56 years, while the patients treated in the intensive care unit (ICU) are even older. About one fourth patients are transferred to the ICU due to complications, such as acute respiratory distress syndrome or shock. 2 Localized involvements of COVID-19, like skin rash, sore throat, hyposmia, anosmia, and oral lesions, have also been mentioned in some literatures. 3, 4 The common oral lesions of COVID-19 include ulcerations, xerostomia, dysgeusia, gingival inflammation, and erythema. [4] [5] [6] According to the associated studies, the most frequent oral finding was oral ulceration, and there were distinct clinical patterns observed in different case studies. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Despite growing literatures investigating oral presentations in COVID-19 patients, few of them provide deep insight into oral ulcerative lesions, the most frequent but diverse one. The detailed clinical features, histological findings, immune profile, and the possible underlying pathogenetic mechanism of the oral ulcerative lesions are still lacking. Therefore, we conducted a comprehensive review of 51 COVID-19 patients with oral ulcerative lesions to further analyze the various oral ulcerative lesions in COVID-19 patients. 16 Although the lesions looked like aphthous ulcerations, patients in these reported cases usually lacked the history of recurrent aphthous stomatitis (RAS), oral inflammatory diseases, or allergy. 10, 13, 18 Besides, some possible etiologic conditions of RAS, such as deficiencies of vitamin B12, folate, and iron were also excluded. 13 The 71-year-old-female in case 26 and the 81-year-old male in case 28 possessed severe clinical presentations of COVID-19 and were admitted to intensive care unit (ICU). Their oral examination showed multiple oral ulcerations with focal necrosis and crusting, and HSV-1 was detected in the saliva sample by performing PCR. 10 The patient in case 33 was also admitted to the ICU and underwent invasive mechanical ventilation. Multiple ulcerations over his oral mucosa were positive for HSV-1 DNA, and HSV-1 reactivation was also proved by the serum tests before and after inpatient care. 18 The patient in case 47 had a past medical history of kidney transplant and took immunosuppressants regularly. He was admitted to ICU for supplemental O2, and his oral lesions exhibited herpes-like ulcers on the dorsal tongue as well as candidiasis.

However, no HSV test was performed to confirm the herpes infection. 19 These extensive ulcerations with necrosis, or co-infection of other pathogens were almost observed in the immunocompromised or older individuals, and usually accompanied with more severe clinical symptoms.

The patients in case 2, 3, 6, 8, 11, 16, 18, 20 and 38 showed oral ulcerations, independent of any systemic symptoms. However, most reported cases showed systemic symptoms concurring or slightly preceding the oral lesions. The latency period from the onset of systemic symptoms to oral lesions were under 10 days, except two cases (case 33 and 47). 9, 10, [13] [14] [15] 18, 19 The mean of the latency period in the 40 reported cases was 3.2 days ( Table 1 ). The mean incubation period of in several studies was reported to be a maximum 8 days and their pooled mean J o u r n a l P r e -p r o o f incubation period was 6.2 days. 20 These findings suggest that the oral ulceration may be one of the early symptoms of COVID-19. In addition, the oral ulcerations may sometimes appear in the asymptomatic patients so that oral ulcerations may be the hint to warn us about the underlying infection in those asymptomatic COVID-19 patients.

patients Based on the current literatures, it seems that there are no pathognomonic findings in these oral ulcerative lesions histologically. The biopsy results revealed non-specific ulcerations with granulation tissue base and diffuse chronic inflammatory cell infiltration. Residual surface epithelium showed edematous change and neutrophilic exocytosis. 14 In addition to the above findings, focal areas of necrosis and hemorrhage were observed in case 45. Besides, both superficial and deep small blood vessels were obliterated by thrombi, which was mainly composed of endothelial cells (positive for CD34) and fibrin. Adjacent minor salivary glands exhibited an intense lymphocytic infiltration. Immunohistochemically, CD3 and CD8 positivities were observed in most inflammatory cells in basal cell layer of the epithelium, in the connective tissue, and in salivary gland tissue. Some other inflammatory cells demonstrated positivities for CD4, CD20, CD68, CD138, and CD163. This immunohistochemical pattern indicates that the components of the inflammatory cells are mainly CD3-positive and CD8positive T lymphocytes. 17 However, biopsy was lack in many cases, so further studies are needed to explore the microscopic details of these oral ulcerative lesions.

The concomitant infections or symptoms in 51 COVID-19 patients with oral ulcerative lesions are shown in Table 2 . For the concomitant infections in 51 COVID-19 patients with oral ulcerative lesions, 4 (7.8%) patients had HSV infection and 2 (3.9%) patients had oral candidiasis. Regarding the concomitant symptoms in 51 COVID-19 patients with oral ulcerative lesions, anosmia or hyposmia (17 patients, 33 .3%) was the most common concomitant symptoms, followed by dysgeusia, ageusia or hypogeusia (9 patients, 17.6%), xerostomia (2 patients, 3.9%), and COVID tongue (geographic tongue-like lesion, 2 patients, 3.9%).

The clinical presentations of the oral ulcerative lesions in COVID-19 patients are various but distinct. Some may look like aphthous ulcerations (minor or herpetiform J o u r n a l P r e -p r o o f type), while there is no evidence of RAS in these patients. These aphtha-like oral lesions occur predominantly in relatively young patients with mild symptoms.

Widespread oral ulcerations accompanied with necrosis are observed in the more severe and immunosuppressed older individuals. This difference may be related to the way by which SARS-CoV-2 infects cells. SARS-CoV-2 enters the cells by the synergy of its own spike protein, angiotensin-converting enzyme 2 (ACE2) on the surface of host cell, and transmembrane protease serine 2 (TMPRSS2). The viral spike protein can recognize ACE2 on the host cell surface, and then TMPRSS2 is triggered to cleave the spike protein for priming cell membrane fusion. 21, 22 The levels of ACE2 and TMPRSS2 are found to be positively correlated with age and the disease severity, which may explain why the elderly tend to possess high risk for severe diseases and why the elderly usually show more widespread and serious oral lesions. 21 The development of the oral ulceration could be possibly associated with the pathogenesis of COVID-19 as well. Because oral epithelial cells have proved to express ACE2, the disruption of oral epithelial cells may occur when the SARS-CoV-2 spread to these epithelial cells. 10 Besides, increased cytokines, such as interleukin 6 (IL-6) and interleukin 10 (IL-10), in COVID-19 patients may lead to chemotaxis of lymphocytes and neutrophils to the lesion site, and thus neutrophilic exocytosis and CD3-positive and CD8-positive lymphocytes are observed in the reported cases. 23 Patients with RAS have been proved to have increased levels of CD8-positive T lymphocytes and/or decreased CD4-positive T lymphocytes by Wardhana and Datau. 24 patients with acute respiratory distress syndrome usually tend to have bacterial, fungal, or viral co-infections. 29 Moreover, xerostomia or dry mouth, the common symptom in COVID-19 patients, may also play a role in causing oral ulcerations in COVID-19 patients. Loss of the protection and lubrication of saliva may easily lead to mucosal trauma and local microbial infections. 30 The occurrence of xerostomia may be attributed to the expression of ACE2 and TMPRSS2 on the salivary gland cells. The infection of salivary gland cells by SARS-CoV-2 finally results in destruction of salivary acinar cells and the impaired saliva-production function. 31 In addition to the salivary gland cells, taste bud cells and olfactory supporting cells are another cells that can express ACE2 and TMPRSS2. 32, 33 Thus, when these cells are infected by SARS-CoV-2, destruction of taste bud cells and olfactory supporting cells may subsequently lead to dysgeusia (or ageusia and hypogeusia) and anosmia (or hyposmia), respectively. 31, 32 The neurotropism of SARS-CoV-2 (i.e., this may result in easy infection of sensory nerves by SARS-CoV-2 and dysfunction of these infected sensory nerves) and the alterations of cytokines in COIVD-19 patients may also play pivotal roles in causing dysgeusia (or ageusia and hypogeusia) and anosmia (or hyposmia). 32, 33 Interestingly, the close relation between xerostomia and dysgeusia as well as the synergy of J o u r n a l P r e -p r o o f gustatory and olfactory systems make the interaction between these oral involvements sophisticated. 33 Fantozzi et al. conducted a survey of 326 COIVD-19 patients with confirmed SARS-CoV-2 infection and reported that dysgeusia was the most common symptom (59.5%), followed by xerostomia (45.9%) and olfactory alterations (hyposmia/anosmia, 41.4%). 4 The most frequently concomitant symptoms in our reported 51 COVID-19 patients with oral ulcerative lesions is anosmia or hyposmia (33.3% of 51 COVID-19 patients), but other symptoms such as dysgeusia (17.6%) and xerostomia (3.9%) were relatively uncommon ( Table 2 ). The relatively-high frequency of the olfactory alterations in our reported cases might also be due to that anosmia or hyposmia was an annoying symptom for the patients and thus the patients usually reported it to the caring physicians. On the contrary, the 51 COVID-19 patients in our study might think that dysgeusia and xerostomia were less disturbing symptoms and thus they forgot to report them to the caring physicians. Besides, 

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Viral exanthem with "Spins and needles sensation" on extremities of a COVID-19 patient: A self-reported case from an Indonesian medical frontliner

gustatory and olfactory dysfunctions in patients with COVID-19

Oral manifestations of COVID-19 disease: A review article

Oral erosions and petechiae during SARS-CoV-2 infection

Considerations on oral manifestations of COVID-19

Association of viral infections with oral cavity lesions: Role of SARS-CoV-2 Infection

Aphthous stomatitis in COVID-19 patients: Case-series and literature review

Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ? Oral Surg Oral Med Oral Pathol Oral Radiol 2021

Aphthous-like stomatitis of COVID-19 patients: case report and review of evidence

Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report

Minor aphthae associated with SARS-CoV-2 infection

Oral cavity lesions as a manifestation of the novel virus (COVID-19)

Oral vesiculobullous lesions associated with SARS-CoV-2 infection

Oral ulceration and blistering in patients with COVID-19

Letter to Editor: Oral lesions in a patient with Covid-19

COVID-19-associated herpetic gingivostomatitis

Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?

The incubation period during the pandemic of COVID-19: a systematic review and meta-analysis

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor

TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19

Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China

Recurrent aphthous stomatitis caused by food allergy

T-lymphocyte subsets in oral mucosa of patients with recurrent aphthous ulceration

Endothelial cell infection and endotheliitis in COVID-19

Viral infections and allergies and immunologic diseases

Primary herpetic gingivostomatitis in children and adults

Dry mouth and its effects on the oral health of elderly people

Existence of SARS-CoV-2 entry molecules in the oral cavity

Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: Identification of cell types and trends with Age

Pathogenesis of in COVID-19 patients: a scoping review

Unexpected presentation of COVID-19 in a 38-year-old male patient: A case report

COVID-19 from the perspective of dentists: A case report and brief review of more than 170 cases

Coronavirus disease 2019-related Kawasaki-like disease in an adult: A case report

al. 16 (2020) herpes-like stomatitis the result) 50 Sinadinos et al. 16 J o u r n a l P r e -p r o o f

Manuscript title: Review of oral ulcerative lesions in COVID-19 patients: a comprehensive study of 51 cases Section I The authors whose names are listed immediately below certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus;membership, employment, consultancies, stock ownership, or other equity interest;and expert testimony or patent licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.Author names:Yu -Hsueh Wu, Yang-Che Wu, Ming-Jane Lang, Yi-Pang Lee, Ying-Tai Jin, Chun-Pin

Sincerely yours,

Section II The authors whose names are listed immediately below report the following details of affiliation or involvement in an organization or entity with a financial or non-financial interest in the subject matter or materials discussed in this manuscript. Please specify the nature of the conflict on a separate sheet of paper if the space below is inadequate.Author names and details of the conflict(s) of interest:J o u r n a l P r e -p r o o f